[Central K1-opiate receptors and mechanisms of arrhythmogenesis].
Ugdyzhekova
D S
DS
Department of Experimental Cardiology, NII of Cardiology of Siberian Department RAMN, Tomsk.
Maslov
L N
LN
Lishmanov
I B
IB
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004399:Dynorphins / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology; D006321:Heart / Q000187:drug effects / Q000294:innervation* / Q000503:physiopathology; D018738:Hexamethonium / Q000494:pharmacology; D007276:Injections, Intraventricular; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D009271:Naltrexone / Q000031:analogs & derivatives / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D017473:Receptors, Opioid, kappa / Q000187:drug effects / Q000378:metabolism*
D005730:Ganglionic Blockers; D009292:Narcotic Antagonists; D017473:Receptors, Opioid, kappa; D009270:Naloxone; C051844:norbinaltorphimine; D018738:Hexamethonium; D009271:Naltrexone; D004399:Dynorphins